Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

Why Now Is a Good Time to Sell Home Depot Shares

By Larry Ramer, InvestorPlace Contributor
A pull-forward of projects this spring and summer, along with a "second wave" of the coronavirus, are among the factors that are likely to hurt Home Depot stock

Steer Clear of ‘Too Hot to Touch’ Wayfair Stock

By Thomas Niel, InvestorPlace Contributor
With more risks than catalysts, buying shares while they remain richly priced does not look like a strong proposition.

As Shares Lose Steam, Now’s the Time to Sell Nvidia Shares

By Thomas Niel, InvestorPlace Contributor
Granted, this winner has kept on winning so far in 2020, but NVDA stock may be topping out. Sell now, as shares remain near all-time highs.

Don’t Bet on Carnival Stock Rebounding Anytime Soon

By Chris Lau, InvestorPlace Contributor
Tracking the drop in coronavirus cases daily in the U.S. may help the cautious investor in timing a better entry point for CCL stock.

Workhorse’s Performance Isn’t Keeping Up With Its Valuation

By Larry Ramer, InvestorPlace Contributor
Given Workhorse's lack of positive catalysts and the high valuation of WKHS stock, investors should sell the shares.

Lowe’s Stock Is Running into Valuation Friction

By Luke Lango, InvestorPlace Senior Investment Analyst
Lowe's is a great company. But LOW stock is overbought and overvalued ahead of what will be a big slowdown over the next few quarters.

3 Terrible Investments That Are Better Than Hertz Stock

By Patrick Sanders, InvestorPlace Contributor
Hertz failed to raise money in its post-bankruptcy stock offering and is now seeking a loan. There's no reason to invest in Hertz stock.

There’s a Reason Why Ocugen Is a Last Resort in Eye Care

By Will Ashworth, InvestorPlace Contributor
Ocugen got good news Aug. 14 announcing a fourth orphan drug designation for its ophthalmology gene therapy. OCGN stock is still a longshot.   

As Summer Turns to Autumn, It’s Time to Sell American Airlines Stock

By Larry Ramer, InvestorPlace Contributor
A second wave of the coronavirus is likely to pressure AAL stock. As a result, investors should sell their shares of the airline.

I’m Bullish on Clean Energy, but Stay Away From FuelCell Energy Stock

By Luke Lango, InvestorPlace Senior Investment Analyst
FuelCell has a bright future in the clean energy revolution, but that bright future is overstated in the current FCEL stock price.

Coca-Cola Lacks Fizz, and Seltzer Isn’t the Answer for KO Stock

By Todd Shriber, InvestorPlace Contributor
In this era of rampant day trading and growth stocks delivering big gains in short order, measuring performance over two decades-plus may not seem relevant, but with consumer staples stocks like Coke and Pepsi, long-term measurement is relevant because investors prize these names for steadiness and typically hold these equities for lengthy periods of time.

Sell Genius Brands After a Far From Brilliant Quarter

By Ian Bezek, InvestorPlace Contributor
GNUS stock ran up on all sorts of news releases this summer. But Q2 earnings showed that the company hasn't turned the corner yet.

According to the Charts, GE Stock Doesn’t Have What It Takes to Pop

By Bret Kenwell, InvestorPlace Contributor
General Electric continues to struggled in a world impacted by the coronavirus. Let's take a deeper look at GE stock and its charts.

Lyft Gets a Reprieve in California, But Challenges Remain

By Todd Shriber, InvestorPlace Contributor
Lyft won an appeals court ruling that allows it to keep operating in California for now, but the fight isn't over for LYFT stock.

Give DocuSign Stock a Little Breathing Room Before Jumping In

By Josh Enomoto, InvestorPlace Contributor
No one will deny that DocuSign stock has been a positively disruptive force this year. However, investors considering DOCU should wait a bit for a better price.

Luckin Stock Is Too Risky Even at This Price

By Charles Sizemore, Chief Investment Strategist, The Freeport Society
Luckin stock was decimated by an accounting scandal that took the shares down more than 95%. Is the stock too cheap to ignore, or should investors still be wary?

There Are Still Too Many Risks In iBio Stock

By Vince Martin, InvestorPlace Contributor
IBIO stock has retreated sharply in recent weeks, and looks more attractive on the dip. But even cheaper, the stock looks like an avoid.

Covid Uncertainty Makes Carnival a Risky Investment

By Tezcan Gecgil, InvestorPlace Contributor
Given the uncertainty as to when leisure travelers may start cruising again, CCL stock is not suitable for every investor.

Overstock.Com Stock Has Had a Massive Run, but It’s Time to Take Profits

By Luke Lango, InvestorPlace Senior Investment Analyst
Not too long ago, OSTK stock was a great buy. Now, it's fully valued, with limited near-term upside potential.
Load More Articles